Search Results - Yinjun Lou
- Showing 1 - 8 results of 8
-
1
-
2
Not BCL2 mutation but dominant mutation conversation contributed to acquired venetoclax resistance in acute myeloid leukemia by Xiang Zhang, Jiejing Qian, Huafeng Wang, Yungui Wang, Yi Zhang, Pengxu Qian, Yinjun Lou, Jie Jin, Honghu Zhu
Published in Biomarker Research (2021-05-01)Get full text
Article -
3
Venetoclax plus arsenic and all-trans retinoic acid in patients with relapsed/refractory acute promyelocytic leukemia by Bingqian Jiang, Hongyan Tong, Min Yang, Huafeng Wang, Shanshan Suo, Chenying Li, Liping Mao, Xingnong Ye, Haitao Meng, Wenjuan Yu, Jie Jin, Yinjun Lou
Published in Blood Cancer Journal (2025-07-01)Get full text
Article -
4
Co-mutation landscape and its prognostic impact on newly diagnosed adult patients with NPM1-mutated de novo acute myeloid leukemia by Yiyi Yao, Yile Zhou, Nanfang Zhuo, Wanzhuo Xie, Haitao Meng, Yinjun Lou, Liping Mao, Hongyan Tong, Jiejing Qian, Min Yang, Wenjuan Yu, De Zhou, Jie Jin, Huafeng Wang
Published in Blood Cancer Journal (2024-07-01)Get full text
Article -
5
Characteristics and predictors of central nervous system relapse in newly diagnosed acute promyelocytic leukemia in the era of arsenic: a 13-year monocenter cohort study by Bingqian Jiang, Hongyan Tong, Haitao Meng, Wanzhuo Xie, Wenjuan Yu, Jian Huang, Huafeng Wang, Liangshun You, Liping Mao, Min Yang, Jiejing Qian, Yanling Ren, Chunmei Yang, Liya Ma, Jie Jin, Yinjun Lou
Published in Blood Cancer Journal (2025-03-01)Get full text
Article -
6
P584: VENETOCLAX PLUS HOMOHARRINGTONINE-BASED CHEMOTHERAPY AS FIRST-LINE TREATMENT FOR ADULTS WITH ACUTE MYELOID LEUKAEMIA: A MULTICENTRE, SINGLE-ARM, PHASE 2 TRIAL by Huafeng Wang, Min Yang, Hongyan Tong, Yinjun Lou, Honghu Zhu, Yue Han, Jiejin Qian, Liping Mao, Chunmei Yang, Ying Lu, Xinping Zhou, Lihong Shou, Haitao Meng, De Zhou, Wenjuan Yu, LI LI, Jie Jin
Published in HemaSphere (2023-08-01)Get full text
Article -
7
Inactivated vaccine dosage and serum IgG levels correlate with persistent COVID-19 infections in hematologic malignancy patients during the Omicron Surge in China by Li Ye, Ye Yang, Xuewu Zhang, Lu Wang, Li Zhu, Xia Li, Yile Zhou, Xiaolong Zheng, Xinping Zhou, Yanling Ren, Liya Ma, Gaixiang Xu, Chunmei Yang, Huafeng Wang, De Zhou, Min Yang, Xingnong Ye, Juying Wei, Wenjuan Yu, Jiejing Qian, Yinjun Lou, Wanzhuo Xie, Jian Huang, Haitao Meng, Jie Jin, Hongyan Tong
Published in BMC Infectious Diseases (2024-10-01)Get full text
Article -
8
The clinical impact of IKZF1 mutation in acute myeloid leukemia by Xiang Zhang, Aijie Huang, Lixia Liu, Jiayue Qin, Chengcheng Wang, Min Yang, Yinjun Lou, Lei Wang, Xiong Ni, Xiaoxia Hu, Gusheng Tang, Mengmeng Zhang, Shanbo Cao, Liping Mao, Jiejin Qian, Weilai Xu, Juying Wei, Gaixiang Xu, Haitao Meng, Wenyuan Mai, Chunmei Yang, Honghu Zhu, Hongyan Tong, Jianmin Yang, Wenjuan Yu, Jianmin Wang, Jie Jin
Published in Experimental Hematology & Oncology (2023-03-01)Get full text
Article
